Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127113711 | 12711371 | 1 | I | 20121029 | 20121031 | 20160902 | 20160902 | EXP | US-PFIZER INC-2012271825 | PFIZER | 81.00 | YR | M | Y | 113.20000 | KG | 20160902 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127113711 | 12711371 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK | Y | 18989 | TABLET | ||||||||
| 127113711 | 12711371 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | Y | 18989 | TABLET | ||||||||||
| 127113711 | 12711371 | 3 | SS | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 10 MEQ, 1X/DAY | Y | 20161 | 10 | MEQ | QD | ||||||
| 127113711 | 12711371 | 4 | SS | DIOVAN HCT | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 320/25 MG, QD | Y | 0 | QD | ||||||||
| 127113711 | 12711371 | 5 | SS | TEKTURNA | ALISKIREN HEMIFUMARATE | 1 | Oral | 300 MG, QD | Y | 0 | 300 | MG | QD | ||||||
| 127113711 | 12711371 | 6 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | UNK, 1X/DAY | 0 | QD | |||||||||
| 127113711 | 12711371 | 7 | C | ASPIRIN. | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 127113711 | 12711371 | 8 | C | TOPROL XL | METOPROLOL SUCCINATE | 1 | UNK | 0 | |||||||||||
| 127113711 | 12711371 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | UNK | 0 | |||||||||||
| 127113711 | 12711371 | 10 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127113711 | 12711371 | 1 | Osteoarthritis |
| 127113711 | 12711371 | 2 | Rheumatoid arthritis |
| 127113711 | 12711371 | 3 | Supplementation therapy |
| 127113711 | 12711371 | 4 | Hypertension |
| 127113711 | 12711371 | 5 | Hypertension |
| 127113711 | 12711371 | 6 | Prophylaxis |
| 127113711 | 12711371 | 7 | Prophylaxis |
| 127113711 | 12711371 | 8 | Hypertension |
| 127113711 | 12711371 | 9 | Hyperlipidaemia |
| 127113711 | 12711371 | 10 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127113711 | 12711371 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127113711 | 12711371 | Acute kidney injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127113711 | 12711371 | 1 | 20120830 | 20121029 | 0 | |
| 127113711 | 12711371 | 3 | 1980 | 20121101 | 0 | |
| 127113711 | 12711371 | 4 | 2011 | 20121101 | 0 | |
| 127113711 | 12711371 | 5 | 2006 | 20121101 | 0 | |
| 127113711 | 12711371 | 6 | 20120830 | 20121029 | 0 | |
| 127113711 | 12711371 | 7 | 1980 | 0 | ||
| 127113711 | 12711371 | 8 | 2003 | 0 | ||
| 127113711 | 12711371 | 9 | 2011 | 0 | ||
| 127113711 | 12711371 | 10 | 2009 | 0 |